MétaCan
Menu
← Back to cohort
Record W4396992510 · doi:10.1681/asn.20213210s1753c

Activins Facilitate TGF-β1 Profibrotic Signaling in Kidneys

2021· article· en· W4396992510 on OpenAlexaff
Asfia Soomro, Dan Zhang, Renzhong Li, Nandita Mehta, Kian S. O'Neil, Bo Gao, Melissa Macdonald, Joan C. Krepinsky

Bibliographic record

VenueJournal of the American Society of Nephrology · 2021
Typearticle
Languageen
FieldMedicine
TopicParathyroid Disorders and Treatments
Canadian institutionsSt. Joseph’s Healthcare HamiltonUniversity of British ColumbiaMcMaster University
Fundersnot available
KeywordsTransforming growth factorSignal transductionInternal medicineMedicineEndocrinologyBiologyCancer researchCell biology

Abstract

fetched live from OpenAlex

Background: Chronic kidney disease (CKD) is a rising health issue in North America. It is characterized by progressive renal fibrosis leading to end-stage kidney disease requiring dialysis or transplantation. TGFβ1 is a central mediator of kidney fibrosis in CKD of diverse etiology. Directly blocking it is unfeasible due to adverse effects. Alternate approaches to inhibit TGFβ1 signaling are needed to develop tolerable antifibrotic therapies. Recent studies suggest that TGFβ1 requires activins for its profibrotic effects. Interesingly, both signal through the same canonical Smad pathway. Here we study the mechanisms by which activins enable TGFβ1-induced fibrosis and assess efficacy of specific activin inhibition in vivo. Methods: Primary mouse kidney mesangial cells (MC) were used. Activin A and B (AA, AB), the predominant activins, were inhibited with a neutralizing antibody or follistatin. ELISA, IF and IB were used to assess cytokine levels, signaling pathways and profibrotic responses. Smad3 transcriptional activity was assessed by CAGA12 luciferase reporter and the alpha smooth muscle actin (αSMA) promoter luciferase. Unilateral ureteral obstruction (UUO) was created in mice overexpressing (OE) TGFβ1 or wild-type controls, and effects of neutralizing anti-AA antibody on kidney fibrosis was assessed. Results: TGFβ1 stimulated the production of AA more than AB, and AA neutralization inhibited the profibrotic effects of TGFβ1. TGFβ1 provoked strong early Smad3 activation (30-60min), while AA did so later (24-48h). Inhibition of AA decreased TGFβ1 (24h)-induced Smad3 activation, assessed by its phosphorylation, nuclear accumulation, and transcriptional activity. Cells retained responsiveness to AA signaling even after becoming refractory to TGFβ1 restimulation, enabling ongoing Smad3 activation. AA additionally regulated noncanonical TGFβ1 signaling. Its inhibition reduced nuclear accumulation of MRTFA, a Smad3 co-mediator of αSMA induction by TGFβ1. Fibrosis was augmented in TGFβ1 OE mice. Neutralizing AA attenuated Smad3 activation and fibrosis in both wild-type and TGFβ1 OE mice. Conclusions: AA facilitates TGFβ1 profibrotic effects through regulation of both canonical (Smad3) and non-canonical (MRTFA) signaling. Importantly, AA inhibition reduced fibrosis in vivo, suggesting a novel potential therapeutic for fibrosis in CKD.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.029
GPT teacher head0.297
Teacher spread0.268 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Society of Nephrology→Same topicParathyroid Disorders and Treatments→French-language works237,207→